Predictors of discontinuation in foslevodopa/foscarbidopa therapy for Parkinson's disease. - Nishikawa N; Hatano T; Kamiyama D; Kamo H; Oji Y; Abe C; Shinada J; Oyama G; Hattori N (Parkinsonism & related disorders, 2025)